ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 24 Issue : 2
Current Issue Archive Popular Article Ahead of Print

 
Effects of proadrenomedullin N-terminal 20 peptide and calcitonin on isolated perfused rat hearts [Anatol J Cardiol]
Anatol J Cardiol. 2009; 9(3): 176-182

Effects of proadrenomedullin N-terminal 20 peptide and calcitonin on isolated perfused rat hearts

Ziya Kaygısız1, Hilmi Özden2, Nilüfer Erkasap1, Tülay Köken3, Murat İkizler4, Tuğrul Kural4
1Department of Physiology, Eskisehir Osmangazi University, Medical Faculty, Eskişehir
2Department of Anatomy Eskisehir Osmangazi University, Medical Faculty, Eskişehir
3Department of Biochemistry, Kocatepe University, Medical Faculty, Afyon, Turkey
4Department of Cardiovascular Surgery Eskisehir Osmangazi University, Medical Faculty, Eskişehir

Objective: There are evidences that proadrenomedullin N-terminal 20 peptide (PAMP) and calcitonin may be involved in cardiovascular function. Therefore, we studied effects of rat PAMP and human PAMP as well as rat calcitonin and salmon calcitonin on coronary perfusion pressure, heart rate and contractile force. Methods: Isolated rat hearts were perfused under constant flow condition and rat PAMP (1.10 and 100 nM), human PAMP (1,10 and 100 nM), rat calcitonin (10.100 and 1000 nM) or salmon calcitonin (10.100 and 1000 nM) were infused to the hearts. Coronary perfusion pressure, heart rate, left ventricular developed pressure and +dP/dtmax were measured. Statistical analysis was performed using repeated measures ANOVA and Bonferroni posthoc tests. Results: Rat PAMP (1.10 and 100 nM) did not alter perfusion pressure. However, it increased heart rate from 257.83 ± 23.89 to 282±24.98 beats/min (p<0.001), from 259.83±25.05 to 289.8±19.5 beats/min (p<0.001) and from 249.66±19.19 to 280.50±25.26 beats/min (p<0.001) for 1.10 and 100 nM, respectively. Rat PAMP decreased left ventricular developed pressure from 90.5±18.5 to 79±15.3 mmHg (p<0.05), from 88.00±10.12 to 73.00±12.38 mmHg (p<0.05) and from 79.83±8.98 to 64.83±10.12 mmHg (p<0.05) for 1.10 and 100 nM, respectively. The peptide also decreased+dP/dtmax from 3710.5±370.6 to 3223.8±261.1 mmHg s-1 (p<0.001), from 3683.16±327.27 to 3040.6±423.8 mmHg s-1 (p<0.01) and from 3746.16±315.76 to 3009.83±204.64 mmHg s-1 ( p<0.001) for 1.10 and 100 nM, respectively. Rat calcitonin (10.100 and 1000 nM) did not change perfusion pressure but it decreased heart rate from 269.16±22.6 to 253.6±22.84 beats/min (p<0.05), from 263.8±27.3 to 247.00±36.63 beats/min (p<0.05) and from 285.0±32.4 to 264.00±39.83 beats/min (p<0.01) for 10.100 and 1000 nM, respectively. Rat calcitonin did not significantly affect left ventricular developed pressure. Human PAMP or salmon calcitonin did not change perfusion pressure, heart rate and left ventricular developed pressure. Conclusion: We conclude that rat PAMP may induce positive chronotropic and negative inotropic effect while rat calcitonin may produce a negative chronotropic effect. Human PAMP or salmon calcitonin could not alter perfusion pressure, heart rate and contractility in isolated, perfused rat hearts.

Keywords: Proadrenomedullin N-terminal 20 peptide, calcitonin, perfusion pressure, heart rate, contractility


Ziya Kaygısız, Hilmi Özden, Nilüfer Erkasap, Tülay Köken, Murat İkizler, Tuğrul Kural. Effects of proadrenomedullin N-terminal 20 peptide and calcitonin on isolated perfused rat hearts. Anatol J Cardiol. 2009; 9(3): 176-182


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2019 Turkish Society of Cardiology